Pubfacts - Scientific Publication Data
  • Categories
  • |
  • Journals
  • |
  • Authors
  • Login
  • Categories
  • Journals

Search Our Scientific Publications & Authors

Publications
  • Publications
  • Authors
find publications by category +
Translate page:

Minireview: new roles for peripheral dopamine on metabolic control and tumor growth: let's seek the balance.

Authors:
Blanca Rubí Pierre Maechler

Endocrinology 2010 Dec 3;151(12):5570-81. Epub 2010 Nov 3.

Departamento de Ciències Experimentals i de la Salut, Universitat Pompeu Fabra, Parc de Recerca Biomèdica de Barcelona, 08003 Barcelona, Spain.

In peripheral tissues, dopamine is released from neuronal cells and is synthesized within specific parenchyma. Dopamine released from sympathetic nerves predominantly contributes to plasma dopamine levels. Despite growing evidence for peripheral source and action of dopamine and the widespread expression of dopamine receptors in peripheral tissues, most studies have focused on functions of dopamine in the central nervous system. Symptoms of several brain disorders, including schizophrenia, Parkinson's disease, attention-deficit hyperactivity disorder, and depression, are alleviated by pharmacological modulation of dopamine transmission. Regarding systemic disorders, the role of dopamine is still poorly understood. Here we describe the pioneering and recent evidence for functional roles of peripheral dopamine. Peripheral and central dopamine systems are sensitive to environmental stress, such as a high-fat diet, suggesting a basis of covariance of peripheral and central actions of dopaminergic agents. Given the extended use of such medications, it is crucial to better understand the integrated effects of dopamine in the whole organism. Delineation of peripheral and central dopaminergic mechanisms would facilitate targeted and safer use of drugs modulating dopamine action. We discuss the increasing evidence for a link between peripheral dopamine and obesity. This review also describes the recently uncovered protective actions of dopamine on energy metabolism and proliferation in tumoral cells.

Download full-text PDF

Source
http://dx.doi.org/10.1210/en.2010-0745DOI Listing
December 2010

Publication Analysis

Top Keywords

dopamine
15
peripheral dopamine
12
peripheral central
12
peripheral
9
dopamine released
8
peripheral tissues
8
roles peripheral
8
crucial better
4
parkinson's disease
4
including schizophrenia
4
modulating dopamine
4
safer drugs
4
drugs modulating
4
schizophrenia parkinson's
4
attention-deficit hyperactivity
4
facilitate targeted
4
depression alleviated
4
disorder depression
4
hyperactivity disorder
4
suggesting basis
4

Altmetric Statistics


Show full details
2 Total Shares
1 Tweets
1 Video Uploads
2 Citations

Similar Publications

A Salience Misattribution Model for Addictive-Like Behaviors.

Authors:
Shivam Kalhan A David Redish Robert Hester Marta I Garrido

Neurosci Biobehav Rev 2021 Feb 28. Epub 2021 Feb 28.

School of Psychological Sciences, University of Melbourne, Melbourne, Victoria, Australia.

Adapting to the changing environment is a key component of optimal decision-making. Internal-models that accurately represent and selectively update from behaviorally relevant/salient stimuli may facilitate adaptive behaviors. Anterior cingulate cortex (ACC) and dopaminergic systems may produce these adaptive internal-models through selective updates from behaviorally relevant stimuli. Read More

View Article and Full-Text PDF
February 2021
Similar Publications

Biomaterials in the Treatment of Parkinson's Disease.

Authors:
Uma Maheswari Krishnan

Neurochem Int 2021 Feb 28:105003. Epub 2021 Feb 28.

Dean, School of Arts, Science & Humanities, Centre for Nanotechnology & Advanced Biomaterials, SASTRA Deemed University, Thanjavur- 613 401, India. Electronic address:

Parkinson's disease is a neurodegenerative disease, the treatment of which is mainly centred around supplementation of dopamine. Additional targets have been identified and newer chemotherapeutic agents have been introduced but their clinical efficacy is limited due to solubility, bioavailability issues and inability to cross the blood-brain barrier (BBB). A wide range of biomaterials ranging from biomolecules, polymers, inorganic metal and metal oxide nanoparticles have been employed to assist the delivery of these therapeutic agents into the brain. Read More

View Article and Full-Text PDF
February 2021
Similar Publications

Age-related changes in expression of lysine48 and lysine63 ubiquitin linkages in dopamine neurons of midbrain in mice.

Authors:
Jing Jiang Xiujuan Hu Lihua Liu Zhicheng He Qingjie Wu Qunchao Li Xianwei Hu Nan Jiang Chao Liu

Neuroreport 2021 Mar 1. Epub 2021 Mar 1.

School of Basic Medical Sciences Department of Histology and Embryology Institute of Stem Cell and Tissue Engineering Institute of Clinical Pharmacology The Second School of Clinical Medicine, Anhui Medical University, Hefei, Anhui, China.

Ubiquitination of target proteins is mediated via different ubiquitin lysine (K) linkages and determines the protein fates. In particular, K48 ubiquitin linkage targets proteins for degradation, whereas K63 ubiquitin linkage plays a nondegradative role. Parkinson's disease is an age-onset neurodegenerative disorder, which shows selective loss of dopamine neurons in substantia nigra pars compacta (SNC) and ubiquitinated protein aggregates. Read More

View Article and Full-Text PDF
March 2021
Similar Publications

Amisulpride: A Review in Post-Operative Nausea and Vomiting.

Authors:
Connie Kang Matt Shirley

Drugs 2021 Mar 3. Epub 2021 Mar 3.

Springer Nature, Mairangi Bay, Private Bag 65901, Auckland, 0754, New Zealand.

Amisulpride intravenous (IV) injection (Barhemsys; hereafter referred to as IV amisulpride), a selective dopamine receptor antagonist, is approved in the USA as a single IV infusion for the prevention and treatment of post-operative nausea and vomiting (PONV) in adults. Results from placebo-controlled phase III trials showed that IV amisulpride is efficacious both in the prevention of PONV (used either alone or in combination with an antiemetic of a different class) and in the treatment of PONV (irrespective of prior antiemetic prophylaxis status). When administered as a single IV infusion, amisulpride had a tolerability profile that was generally similar to that of placebo, with no significant safety concerns identified. Read More

View Article and Full-Text PDF
March 2021
Similar Publications

Dopamine Precursor Depletion in Healthy Volunteers Impairs Processing of Duration but Not Temporal Order.

Authors:
Morgane Chassignolle Ljubica Jovanovic Catherine Schmidt-Mutter Guillaume Behr Anne Giersch Jennifer T Coull

J Cogn Neurosci 2021 Mar 3:1-18. Epub 2021 Mar 3.

Aix Marseille University & CNRS, France.

Studies in animals and humans have implicated the neurotransmitter dopamine in duration processing. However, very few studies have examined dopamine's involvement in other forms of temporal processing such as temporal order judgments. In a randomized within-subject placebo-controlled design, we used acute phenylalanine/tyrosine depletion (APTD) to reduce availability of the dopamine precursors tyrosine and phenylalanine in healthy human volunteers. Read More

View Article and Full-Text PDF
March 2021
Similar Publications
© 2021 PubFacts.
  • About PubFacts
  • Privacy Policy
  • Sitemap